Norman Swann
speaker
14,464 appearances
150 recordings
1 series
first heard Jul 2005
last heard Feb 2013
Norman Swann’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
Something that doctors are pushing pretty cholesterol redoing drugs, something that doctors are pushing pretty hard.
And compared to a control group who didn't get this, what was the difference in decision making?
So they're already giving a huge amount of information in the control group and this is on top.
And so you've got that magnitude of difference on top.
And so this was self selecting.
So if they got the decision tool, if they were at low risk and their numbers were that or high, they were kind of making a reasonably sensible decision it might not be worth doing.
Whereas if it was high risk, they were tending to make the kind of the right decision.
Yeah, we we tried to write being a violent word.
to take that, so now we've got nine rows of ten of green who are not going to get a heart attack with no statin and one row of ten with red.
Now you go that the one row of ten with red, there's two out of that.
So a hundred people have got to be treated for two people to benefit.
Professor Victor Montori is in the divisions of endocrinology and healthcare policy and research at the Mayo Clinic in Rochester, Minnesota.
And you've decided, on excellent grounds, I might say, to take the health report here on ABC Radio National.
Now, to be fair, there are GPs and specialists in Australia who regularly use tools like risk calculators and charts like the one Victor Montori showed me, but they're probably the exception rather than the rule.
Even with the best will in the world, it's hard to loosen up a training which has concentrated on why people get diseases and what can be done about them.
It's all very well knowing the research, but if the doctor doesn't focus on what the person wants when confronted with the evidence, it can become rather pointless.
Because people can have very good reasons for not doing what the evidence says is best for them.
And the consequences, as you heard, may not be that bad.
Anyway, Victor Montori and his colleagues went on to do a second study looking at the treatment of high blood sugar in people with type two or adult onset diabetes.
Why don't you try me out in this one?
Showing 541–560 of 14,464 · page 28 of 724
← Previous
Next →